INBIOGEN CO., Ltd.

INBIOGEN CO., Ltd.

KKRX:101140
4,870.00
KRW
-55.00
(-1.12%)
-2,723.83EPS
58.61BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
14,186.05
20,600.79
9,572.43
11,464.02
6,428.37
6,638.47
6,120.17
4,941.4
3,903.93
76,530.85
733.33
705.31
630.27
670.67
Basic EPS, GAAP
-2,458
-2,824
-6,140
-2,240
-1,100
1,460
8,200
-21,800
35,060
-860,961.66
1,333
1,615
-142
-2,723.83
Free Cash Flow per Basic Share
-2,209.05
-1,261.39
-11,981.92
342.32
-387.37
-1,490.56
-2,651.63
-4,354.38
-3,527.71
-86,933.44
-162.35
-11.76
-560.18
-484.46
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
6,539.83
6,117.49
7,790.11
5,744.26
9,581.38
16,714.99
34,189.09
30,849.95
68,023.17
15,287.73
14,330.1
16,007.99
15,788.35
14,171.82
Tangible Book Value per Share
6,514.7
6,107.69
7,785.96
5,742.37
9,581.38
16,714.99
34,125.52
30,637.75
67,846.42
15,214.65
14,265.07
15,988.88
15,788.35
14,160.84
Basic Weighted Avg Shares
1
1
1
1
1
1
2
2
3
- -
9
10
10
8
Sales/Revenue/Turnover
7,966
11,762
8,865
11,545
7,077
7,566
9,795
10,218
10,481
10,420
6,241
7,041
6,297
5,104
Operating Margin (%)
-16.12
-10.85
-55.81
-18.47
-21.64
18.07
-21.71
-52.95
-73.33
-57.28
-98.38
-86.45
-68.81
-76.63
Depreciation Expense
46
40
52
52
49
35
255
443
1,117
1,438
1,224
1,057
363
126
Net Income, GAAP
-1,380
-1,612
-5,686
-2,256
-1,211
1,664
13,124
-45,078
94,125
-117,218
11,344
16,122
-1,419
-20,727
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
15.25
- -
- -
- -
- -
- -
Profit Margin (%)
-17.33
-13.71
-64.14
-19.54
-17.11
21.99
133.98
-441.17
898.07
-1,124.99
181.77
228.98
-22.53
-406.14
Working Capital
6,462
4,421
10,901
6,368
12,001
23,320
8,382
67,715
-45,873
-19,628
9,218
7,164
3,460
1,872
LT Debt
2,596
- -
2,811
318
318
- -
118
246
1,064
553
330
668
426
299
Total Equity
3,670
4,124
7,800
5,751
11,324
23,352
65,996
77,906
178,023
106,884
143,083
159,837
157,644
141,503
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
-4.63
- -
-4.95
- -
-4.91
-4.02
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
35.04
- -
71.05
- -
9.2
10.63
- -
- -
Return on Common Equity (%)
-33.69
-41.38
-95.38
-33.3
-14.18
9.6
29.38
-62.65
73.56
-82.29
9.08
10.64
-0.89
-13.63

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
741
3,746
3,750
LT Borrowings
- -
- -
- -
LT Finance Leases
426
363
299
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
10
10
10
Market Capitalization
104,740
96,553
58,611

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
5,321
7,744
6,896
Cash, Cash Equivalents & STI
902
3,533
2,339
Accounts Receivable, Net
486
501
528
Inventories
30
- -
- -
Total Current Liabilities
1,862
4,937
5,023
Payables & Accruals
- -
- -
- -
ST Debt
741
3,746
3,750
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
51.03%
26.55%
-1.37%
Free Cash Flow
475.05%
903.4%
4,666.66%
Net Income, GAAP
-80.86%
-141.94%
-108.8%
Sales/Revenue/Turnover
-0.36%
-7.17%
-10.57%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,369
1,424
2,081
2,167
7,041
2025
1,639
1,850
2,147
661
6,297
2026
786
1,510
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
861
-435
-443
29,644.29
1,615
2025
203
113
818.34
-25,528.27
-142
2026
-1,470
-148
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Ji-Yeon Kang
Full Time Employees
28
Sector
Electronic technology
Industry
Electronic equipment/Instruments
Address
Initial Tower ' Seoul SL South Korea 17908
IPO Date
Apr 2, 2008
Business
INBIOGEN Co., Ltd. (101140.KS) manufactures and distributes footwear products; operates unmanned kiosks for payments; distributes wood pellets and sawdust; and engages in food and beverage businesses, including online and offline education for FinTech, platform, and blockchain human resources development. The company operates through four segments—kiosk business providing unmanned payment machines for restaurants, karaoke rooms, and PC rooms; footwear business selling children's and adult shoes such as hiking, skate, and running shoes; wood pellet business; and other businesses—primarily targeting the South Korean market. Founded in 1949 and headquartered in Seoul at Initial Tower, 6th and 7th floors, Gangnam-gu, INBIOGEN focuses on wholesale distribution of computers, peripheral equipment, and software alongside its core operations. Previously known as BTOne Co., Ltd., the company underwent a significant name change to INBIOGEN Co., Ltd., reflecting a strategic shift in its business identity and operations. In November 2022, INBIOGEN received KRW 12 billion in funding from Bucket Studio Co., Ltd., supporting its diversified portfolio expansion. These developments underscore recent financial strengthening and adaptation across its kiosk, footwear, and related segments amid ongoing market dynamics in South Korea.